Motivated by the imperative to enhance diagnostic accuracy and streamline treatment strategies, this study seeks to delve into the multifaceted factors influencing Ga68 PSMA PET-CT uptake for primary staging in prostate cancer cases. This evidence concerns the gene FOLH1 and prostate cancer.